RxDoctor Payments DataLook up a doctor →

David Baker

Physician Assistant · Fresno, CANPI 1962583740

Payments from drug & device makers

$36,886in general payments, 2019–2025

Across 1,247 payments — averaging $29.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Eisai Inc.$5K
  • AbbVie$5K
  • Pfizer$2K
  • Biogen$2K
  • UCB, Inc.$2K
  • SK Life Science, Inc.$1K
  • plus $20K from 54 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Eisai Inc.53$5,146
AbbVie(2 entities)135$4,565
Pfizer24$1,996
Biogen50$1,717
UCB, Inc.66$1,590
SK Life Science, Inc.92$1,462
Ipsen Pharma SAS2$1,418
Amgen(2 entities)20$1,233
AstraZeneca(2 entities)65$1,178
Ipsen Innovation3$1,174
MDD US Operations, LLC22$967
ANI Pharmaceuticals, Inc.55$963
Lundbeck LLC19$867
Novartis59$862
EMD Serono, Inc.36$819
Teva Pharmaceuticals USA, Inc.36$674
Neurelis, Inc.29$615
Neurocrine Biosciences, Inc.23$614
Axsome Therapeutics, Inc.19$544
Acadia Pharmaceuticals Inc26$522
Takeda Pharmaceuticals U.S.A., Inc.24$501
Amneal Pharmaceuticals LLC32$481
Mallinckrodt Hospital Products Inc.32$480
Genentech USA, Inc.23$464
Argenx US, Inc.21$436
Johnson & Johnson(2 entities)19$415
Kyowa Kirin, Inc.20$379
Banner Life Sciences, LLC21$344
CSL Behring16$326
Merz Pharmaceuticals, LLC10$274
Biohaven Pharmaceuticals, Inc.14$268
Harmony Biosciences LLC11$254
Biohaven Pharmaceutical Holding Company Ltd.14$251
Sunovion Pharmaceuticals Inc.14$246
Supernus Pharmaceuticals, Inc.15$234
Bristol Myers Squibb12$219
Jazz Pharmaceuticals Inc.10$196
Octapharma USA, Inc.6$134
GE HealthCare9$132
Vanda Pharmaceuticals Inc.6$123
Lilly USA, LLC6$121
Ipsen Biopharmaceuticals, Inc6$114
Catalyst Pharmaceuticals, Inc.6$110
Virtus Pharmaceuticals LLC1$107
TG Therapeutics, Inc.5$102
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC8$102
Boston Scientific2$102
Medtronic1$98
Sumitomo Pharma America, Inc.5$95
Acorda Therapeutics, Inc5$94
Sanofi5$82
Otsuka America Pharmaceutical, Inc.4$75
Alnylam Pharmaceuticals Inc.3$70
Scilex Pharmaceuticals Inc.3$63
Avanir Pharmaceuticals, Inc.3$62
Adamas Pharmaceuticals, Inc.3$59
Zogenix Inc.3$55
E.r. Squibb & Sons, L.L.C.2$42
Grifols USA, LLC2$40
Upsher-smith Laboratories LLC2$36

How this compares

$36,886 in reported general payments places this provider in the 95th percentile of 10,423 physician assistant providers in California.

See all physician assistant providers in California →

Medicare billing

Part B allowed, 2024
$1,772
Medicare patients
14
Services billed
17

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other physician assistant in Fresno

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →